242 results on '"Di Bonito M"'
Search Results
2. Towards a broad-based and holistic framework of Sustainable Intensification indicators
3. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women
4. The Clinical and Translational Research Activities at the INT – IRCCS 'Fondazione Pascale' Cancer Center (Naples, Italy) during the COVID-19 Pandemic
5. Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908
6. Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer
7. P-198 Prevalence of deleterious DPYD variants in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy
8. Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
9. Chapter 11 - Models of Geochemical Speciation: Structure and Applications
10. A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study
11. Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients
12. CISPLATIN-EPIRUBICIN-PACLITAXEL (PET) WEEKLY ADMINISTRATION VS. EPIRUBICIN-PACLITAXEL (ET) IN LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
13. HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer
14. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression
15. Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
16. How the 70-gene tumour expression profile 'MammaPrint' can assist in St Gallen 2009 treatment recommendations in 12 Italian hospitals
17. THE 70-GENE EXPRESSION PROFILE FOR BREAST CANCERPATIENTS IN ITALIAN HOSPITALS
18. A novel form of hyper-IgM syndrome
19. CHAPTER ELEVEN - SEWAGE SLUDGE IN EUROPE AND IN THE UK: ENVIRONMENTAL IMPACT AND IMPROVED STANDARDS FOR RECYCLING AND RECOVERY TO LAND
20. Oral Betamethasone improves neurological symptoms in Ataxia-Teleangiectasia
21. Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes
22. Functional characterization of patients with autoimmunity and defective lymphocyte apoptosis: role of caspases
23. Cycloossigenase 2 expression is associated with increased size in human sporadic colorectal adenomas
24. Cartografia Geochimica della Sardegna (Sardinia Geochemical Mapping)
25. How the 70-gene tumour expression profile 'MammaPrint' can assist in St Gallen 2009 treatment recommendations in 12 Italian hospitals
26. A rhombomere 4-derived auditory circuitry is dependent on Hoxb1 function
27. Cartografia geochimica della Sardegna
28. Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.
29. PR24 Difference of clinical features and molecular subtypes between under-forty and post-menopausal breast cancer patients in southern Italy
30. Overview of selected soil pore water extraction methods for the determination of potentially toxic elements in contaminated soils : operational and technical aspects
31. Relapse in breast cancer: How much mode of breast cancer detection matters? Results from an Italian national cancer institute.
32. 102 How the 70-gene tumour expression profile “MammaPrint” can assist in St Gallen 2009 treatment recommendations in 12 Italian hospitals
33. Weekly cisplatin-epirubicin-paclitaxel with G-CSF support in ER-negative large operable breast cancer. The NCI of Naples’ nine-year experience
34. Outcome Analysis of Breast Cancer Patients Receiving Breast-Conserving Surgery in Southern Italy
35. Environmental geochemistry : an aid to the development and regeneration of the urban environment
36. Weekly cisplatin-epirubicin-paclitaxel (PET) with granulocyte-colony stimulating factor support versus tri-weekly epirubicin-paclitaxel in locally advanced breast cancer: Final comprehensive and subgroup analysis of a SICOG phase III study
37. A two-month cisplatin-epirubicin-paclitaxel (PET) weekly administration is highly effective in large operable breast cancer. Final analysis of a SICOG phase II study
38. Two-month cisplatin-epirubicin-paclitaxel (PET) weekly administration for the treatment of large operable breast cancer. SICOG 0105 phase II study
39. 959 Expression of functional CXCR4 on colorectal human cancer
40. Progressive impairment of developing neuroendocrine cell lineages in the hypothalamus of mice lacking the Orthopedia gene
41. Weekly docetaxel (D) plus gemcitabine (G) or vinorelbine (V) in refractory advanced breast cancer (ABC) patients. A parallel dose-finding study
42. QU.A.RT. versus SSM + TRAM flap immediate breast reconstruction in T2 > 3cm n0-1 m0 breast cancer: Preliminary data
43. Baseline geochemical mapping of Sardinia (Italy)
44. P912. Core biopsy in locally advanced breast cancer
45. Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study
46. Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.
47. Monoclonal antibody localization of A,B,H isoantigens in common epithelial tumors of the ovary
48. [The secretory IgA system and breast cancer]
49. Acne radar: A new intuitive graphic visualization of quality of life in acne patients
50. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.